Inflammation and Neurodegeneration in Glaucoma: Isolated Eye Disease or a Part of a Systemic Disorder? - Serum Proteomic Analysis

References

• Shpak AA, Guekht AB, Druzhkova TA, Troshina AA, Gulyaeva NV. Glial cell line-derived neurotrophic factor (GDNF) in patients with primary open-angle glaucoma and age-related cataract. Mol Vis. 2022;28:39–47.
   PubMed Web of Science ®Google Scholar
• Kang JM, Tanna AP. Glaucoma. Med Clin North Am. 2021;105(3):493–510. doi:10.1016/j.mcna.2021.01.004
   PubMed Web of Science ®Google Scholar
• Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–2090. doi:10.1016/j.ophtha.2014.05.013
   PubMed Web of Science ®Google Scholar
• He S, Stankowska DL, Ellis DZ, Krishnamoorthy RR, Yorio T. Targets of Neuroprotection in Glaucoma. J Ocul Pharmacol Ther. 2018;34(1–2):85–106. doi:10.1089/jop.2017.0041
   PubMed Web of Science ®Google Scholar
• Kuo CY, Liu CJL. Neuroprotection in Glaucoma: basic Aspects and Clinical Relevance. J Personalized Me. 2022;12(11):1884. doi:10.3390/jpm12111884
   PubMed Web of Science ®Google Scholar
• Vidal-Villegas B, Burgos-Blasco B, Santiago Alvarez JL, et al. Proinflammatory Cytokine Profile Differences between Primary Open-Angle and Pseudoexfoliative Glaucoma. Ophthalmic Res. 2021;65(1):111–120. doi:10.1159/000519816
   PubMed Web of Science ®Google Scholar
• Abu-Amero KK, Kondkar AA, Mousa A, Osman EA, Al-Obeidan SA. Decreased total antioxidants status in the plasma of patients with pseudoexfoliation glaucoma. Mol Vis. 2011;17:2769–2775.
   PubMed Web of Science ®Google Scholar
• Aslan M, Cort A, Yucel I. Oxidative and nitrative stress markers in glaucoma. Free Radic Biol Med. 2008;45(4):367–376. doi:10.1016/j.freeradbiomed.2008.04.026
   PubMed Web of Science ®Google Scholar
• Khalef N, Labib H, Helmy H, El Hamid MA, Moemen L, Fahmy I. Levels of cytokines in the aqueous humor of eyes with primary open angle glaucoma, pseudoexfoliation glaucoma and cataract. Electron Physician. 2017;9(2):3833–3837. doi:10.19082/3833
   PubMedGoogle Scholar
• Chono I, Miyazaki D, Miyake H, et al. High interleukin-8 level in aqueous humor is associated with poor prognosis in eyes with open angle glaucoma and neovascular glaucoma. Sci Rep. 2018;8(1):14533. doi:10.1038/s41598-018-32725-3
   PubMed Web of Science ®Google Scholar
• Yin Z, Gao Y, Tang Y, Tian X, Zheng Y, Han Q. Aqueous humor cytokine levels are associated with the severity of visual field defects in patients with primary open-angle glaucoma. BMC Ophthalmology. 2023;23(1):141. doi:10.1186/s12886-023-02875-8
   PubMed Web of Science ®Google Scholar
• Schuettauf F, Vorwerk C, Naskar R, et al. Adeno-associated viruses containing bFGF or BDNF are neuroprotective against excitotoxicity. Curr Eye Res. 2004;29(6):379–386. doi:10.1080/02713680490517872
   PubMed Web of Science ®Google Scholar
• Lambiase A, Aloe L, Centofanti M, et al. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma. Proc Natl Acad Sci U S A. 2009;106(32):13469–13474. doi:10.1073/pnas.0906678106
   PubMed Web of Science ®Google Scholar
• Ji JZ, Elyaman W, Yip HK, et al. CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway. Eur J Neurosci. 2004;19(2):265–272. doi:10.1111/j.0953-816x.2003.03107.x
   PubMed Web of Science ®Google Scholar
• Koeberle PD, Ball AK. Neurturin enhances the survival of axotomized retinal ganglion cells in vivo: combined effects with glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor. Neuroscience. 2002;110(3):555–567. doi:10.1016/s0306-4522(01)00557-7
   PubMed Web of Science ®Google Scholar
• Chlabicz M, Jamiołkowski J, Łaguna W, et al. A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: a Population-Based Study. J Clin Med. 2021;10(8):1584. doi:10.3390/jcm10081584
   PubMed Web of Science ®Google Scholar
• Spaeth GL. European glaucoma society terminology and guidelines for glaucoma. Br J Ophthalmol. 2021;105(Suppl 1):1–169. doi:10.1136/bjophthalmol-2021-egsguidelines
   Web of Science ®Google Scholar
• Cheng KKW, Tatham AJ. Spotlight on the Disc-Damage Likelihood Scale (DDLS). Clin Ophthalmol. 2021;15:4059–4071. doi:10.2147/OPTH.S284618
   PubMed Web of Science ®Google Scholar
• Bochmann F, Howell JP, Meier C, Becht C, Thiel MA. The disc damage likelihood scale (DDLS): interobserver agreement of a new grading system to assess glaucomatous optic disc damage. Klin Monbl Augenheilkd. 2009;226(4):280–283. doi:10.1055/s-0028-1109288
   PubMed Web of Science ®Google Scholar
• Susanna R, Vessani RM. New findings in the evaluation of the optic disc in glaucoma diagnosis. Curr Opin Ophthalmol. 2007;18(2):122–128. doi:10.1097/ICU.0b013e328040bfe0
   PubMed Web of Science ®Google Scholar
• Fingeret M, Medeiros FA, Susanna R, Weinreb RN. Five rules to evaluate the optic disc and retinal nerve fiber layer for glaucoma. Optometry. 2005;76(11):661–668. doi:10.1016/j.optm.2005.08.029
   PubMedGoogle Scholar
• R Core Team. R: a language and environment for statistical computing. 2022. Available from: https://www.R-project.org/. Accessed February 6, 2024.
   Google Scholar
• American Diabetes Association Professional Practice Committee. 2. Classification and Diagnosis of Diabetes: standards of Medical Care in Diabetes—2022. Diabetes Care. 2021;45(Supplement_1):S17–S38. doi:10.2337/dc22-S002
   Google Scholar
• Li S, Cao W, Han J, Tang B, Sun X. The diagnostic value of white blood cell, neutrophil, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in patients with primary angle closure glaucoma. Oncotarget. 2017;8(40):68984–68995. doi:10.18632/oncotarget.16571
   PubMedGoogle Scholar
• Ozgonul C, Sertoglu E, Mumcuoglu T, Kucukevcilioglu M. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Novel Biomarkers of Primary Open-Angle Glaucoma. J Glaucoma. 2016;25(10):e815–e820. doi:10.1097/IJG.0000000000000392
   PubMed Web of Science ®Google Scholar
• Zhang A, Ning L, Han J, et al. Neutrophil-To-Lymphocyte Ratio as a Potential Biomarker of Neovascular Glaucoma. Ocul Immunol Inflamm. 2021;29(2):417–424. doi:10.1080/09273948.2019.1677916
   PubMed Web of Science ®Google Scholar
• Atalay K, Kaldirim Erdogan H, Kirgiz A, Asik Nacaroglu S. Predictive role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in normal-tension glaucoma. Med Hypotheses. 2017;103:54–56. doi:10.1016/j.mehy.2017.04.001
   PubMed Web of Science ®Google Scholar
• Kurtul BE, Ozer PA, Kabatas EU. Elevated neutrophil-to-lymphocyte ratio in pseudoexfoliation syndrome. Eye (Lond). 2016;30(8):1045–1048. doi:10.1038/eye.2016.89
   PubMed Web of Science ®Google Scholar
• Zhao YX, Chen XW. Diabetes and risk of glaucoma: systematic review and a Meta-analysis of prospective cohort studies. Int J Ophthalmol. 2017;10(9):1430–1435. doi:10.18240/ijo.2017.09.16
   PubMed Web of Science ®Google Scholar
• Nakamura M, Kanamori A, Negi A. Diabetes mellitus as a Risk Factor for Glaucomatous Optic Neuropathy. Ophthalmologica. 2005;219(1):1–10. doi:10.1159/000081775
   PubMed Web of Science ®Google Scholar
• Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J Diabetes. 2015;6(1):92–108. doi:10.4239/wjd.v6.i1.92
   PubMed Web of Science ®Google Scholar
• Lee JS, Kim YJ, Kim S, et al. Increased Risks of Open-Angle Glaucoma in Untreated Hypertension. Am J Ophthalmol. 2023;252:111–120. doi:10.1016/j.ajo.2023.03.032
   PubMed Web of Science ®Google Scholar
• Nislawati R, Taufik Fadillah Zainal A, Ismail A, Waspodo N, Kasim F, Gunawan AMAK. Role of hypertension as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. BMJ Open Ophth. 2021;6(1):e000798. doi:10.1136/bmjophth-2021-000798
   PubMed Web of Science ®Google Scholar
• Graßhoff H, Comdühr S, Monne LR, et al. Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases. Front Immunol. 2021:12. doi:10.3389/fimmu.2021.648408
   Google Scholar
• Witkowska AM. On the Role of sIL-2R Measurements in Rheumatoid Arthritis and Cancers. Mediators of Inflammation Nan/Nan/Nan. 2005;121–130. doi:10.1155/MI.2005.121
   Google Scholar
• LaPorte KM, Hernandez R, Savio AS, Malek TR. Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8+ T cells. J Immunother Cancer. 2023;11(6):e006611. doi:10.1136/jitc-2022-006611
   PubMed Web of Science ®Google Scholar
• Liang G, Li J, Pu S, He Z. Screening of Sepsis Biomarkers Based on Bioinformatics Data Analysis. J Healthcare Engineering. 2022;2022:e6788569. doi:10.1155/2022/6788569
   PubMed Web of Science ®Google Scholar
• Lu J, Li Q, Wu Z, et al. Two gene set variation indexes as potential diagnostic tool for sepsis. Am J Transl Res. 2020;12(6):2749.
   PubMed Web of Science ®Google Scholar
• Lou W, Yan J, Wang W. Downregulation of miR-497-5p Improves Sepsis-Induced Acute Lung Injury by Targeting IL2RB. Biomed Res Int. 2021;2021:6624702. doi:10.1155/2021/6624702
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang Y, Li S, et al. A Robust and Generalizable Immune-Related Signature for Sepsis Diagnostics. IEEE/ACM Trans Comput Biol Bioinform. 2022;19(6):3246–3254. doi:10.1109/TCBB.2021.3107874
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhang Y, Zhuang Q. IL2RB affects Th1/Th2 and Th17 responses of peripheral blood mononuclear cells from septic patients. Allergologia et Immunopathologia. 2023;51(3):1–7. doi:10.15586/aei.v51i3.757
   PubMed Web of Science ®Google Scholar
• Ghosh SP, Yu Z, Kelegere Y, et al. Evidence for IL-2 signaling in corneal epithelium. Invest Ophthalmol Visual Sci. 2022;63(7).
   Web of Science ®Google Scholar
• Barak V, Kalickman I, Pe’er J. sIL-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma. Anticancer Res. 2022;42(3):1447–1453. doi:10.21873/anticanres.15615
   PubMed Web of Science ®Google Scholar
• Cénit MC, Márquez A, Cordero-Coma M, et al. Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition. BMC Med. Genet. 2013;14(1):52. doi:10.1186/1471-2350-14-52
   PubMedGoogle Scholar
• Suzuki K, Namba K, Mizuuchi K, et al. Validation of systemic parameters for the diagnosis of ocular sarcoidosis. Jpn J Ophthalmol. 2021;65(2):191–198. doi:10.1007/s10384-020-00793-6
   PubMed Web of Science ®Google Scholar
• Gundlach E, Hoffmann MM, Prasse A, Heinzelmann S, Ness T. Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis. PLoS One. 2016;11(1):e0147258. doi:10.1371/journal.pone.0147258
   PubMed Web of Science ®Google Scholar
• Alende-Castro V, Alonso-Sampedro M, Fernández-Merino C, et al. Factors influencing serum concentrations of soluble interleukin-2 receptor: a general adult population study. All Life. 2023;16(1):2169958. doi:10.1080/26895293.2023.2169958
   Web of Science ®Google Scholar
• Cai B, Zhang J, Zhang M, et al. Micro-inflammation characterized by disturbed Treg/Teff balance with increasing sIL-2R in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2013;121(4):214–219. doi:10.1055/s-0033-1333687
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang Y, Zhao M, Li Q, Li H. sIL-2R levels predict the spontaneous remission in sarcoidosis. Respir Med. 2020;171. doi:10.1016/j.rmed.2020.106115
   Web of Science ®Google Scholar
• Vorselaars ADM, van CHM, Zanen P, et al. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy. Respir Med. 2015;109(2):279–285. doi:10.1016/j.rmed.2014.11.009
   PubMed Web of Science ®Google Scholar
• Gupta S, Parmar M, Padappayil RP, Bansal A, Daouk S. Role of Serum Soluble Interleukin-2 Receptor Level in the Diagnosis of Sarcoidosis: a Systematic Review and Meta-Analysis. Int J Med. 2022;22277713. doi:10.1101/2022.07.16.22277713
   Google Scholar
• Schimmelpennink M, Quanjel M, Vorselaars A, et al. Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis. Expert Rev Respir Med. 2020;14(7):749–756. doi:10.1080/17476348.2020.1751614
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Sato T, Nagai T, et al. Association of high serum soluble interleukin 2 receptor levels with risk of adverse events in cardiac sarcoidosis. ESC Heart Failure. 2021;8(6):5282–5292. doi:10.1002/ehf2.13614
   PubMed Web of Science ®Google Scholar
• Al-Hakeim HK, Al-Rammahi DA, Al-Dujaili AH. IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation. J Affective Disorders. 2015;182:106–114. doi:10.1016/j.jad.2015.04.044
   PubMed Web of Science ®Google Scholar
• Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD. Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5083 controls. Brain Behav Immun. 2020;87:901–909. doi:10.1016/j.bbi.2020.02.010
   PubMed Web of Science ®Google Scholar
• Maes M, Carvalho AF. The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder. Mol Neurobiol. 2018;55(12):8885–8903. doi:10.1007/s12035-018-1016-x
   PubMed Web of Science ®Google Scholar
• Lindqvist D, Kaufman E, Brundin L, Hall S, Surova Y, Hansson O. Non-Motor Symptoms in Patients with Parkinson’s Disease – correlations with Inflammatory Cytokines in Serum. PLoS One. 2012;7(10):e47387. doi:10.1371/journal.pone.0047387
   PubMed Web of Science ®Google Scholar
• Ramanzini LG, Camargo LFM, Silveira JOF, Bochi GV. Inflammatory markers and depression in Parkinson’s disease: a systematic review. Neurol Sci. 2022;43(12):6707–6717. doi:10.1007/s10072-022-06363-7
   PubMed Web of Science ®Google Scholar
• Nies YH, Yahaya MF, Lim WL, Teoh SL. Microarray-based analysis of differential gene expression profile in rotenone-induced Parkinson’s disease zebrafish model. CNS Neurol Disord Drug Targets. 2023. doi:10.2174/1871527322666230608122552
   PubMedGoogle Scholar
• Moffatt MF, Gut IG, Demenais F, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med. 2010;363(13):1211–1221. doi:10.1056/NEJMoa0906312
   PubMed Web of Science ®Google Scholar
• Brunner PM, Suárez-Fariñas M, He H, et al. The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins. Sci Rep. 2017;7(1):8707. doi:10.1038/s41598-017-09207-z
   PubMed Web of Science ®Google Scholar
• Sun H, Liu C, Zhang X, et al. Using bioinformatics analysis to screen abnormal methylated differentially expressed hub genes of Kawasaki disease and construct diagnostic model. Heliyon. 2022;8(11):e11905. doi:10.1016/j.heliyon.2022.e11905
   PubMed Web of Science ®Google Scholar
• Liao Y, Ke B, Long X, Xu J, Wu Y. Upregulated Expression of IL2RB Causes Disorder of Immune Microenvironment in Patients with Kawasaki Disease. Biomed Res. Int. 2022;2022:e2114699. doi:10.1155/2022/2114699
   PubMed Web of Science ®Google Scholar
• Hinks A, Cobb J, Marion MC, et al. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet. 2013;45(6):664–669. doi:10.1038/ng.2614
   PubMed Web of Science ®Google Scholar
• Zheng Y, Cai B, Ren C, et al. Identification of immune related cells and crucial genes in the peripheral blood of ankylosing spondylitis by integrated bioinformatics analysis. PeerJ. 2021;9:e12125. doi:10.7717/peerj.12125
   PubMed Web of Science ®Google Scholar
• Akiyama M, Sasaki T, Kaneko Y, et al. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren’s syndrome adults from a defined population. Clin Exp Rheumatol. 2018;36 Suppl 112(3):157–164.
   PubMed Web of Science ®Google Scholar
• Keindl M, Davies R, Bergum B, et al. Impaired activation of STAT5 upon IL-2 stimulation in Tregs and elevated sIL-2R in Sjögren’s syndrome. Arthritis Res Therapy. 2022;24(1):101. doi:10.1186/s13075-022-02769-y
   PubMed Web of Science ®Google Scholar
• Hamamoto K, Inaba M, Yamada S, et al. Increased soluble IL-2 receptor levels in serum from a patient with painless thyroiditis. Thyroid Research. 2013;6(1):12. doi:10.1186/1756-6614-6-12
   PubMedGoogle Scholar
• Bouzid D, Amouri A, Fourati H, et al. Polymorphisms in the IL2RA and IL2RB Genes in Inflammatory Bowel Disease Risk. Genetic Testing and Molecular Biomarkers. 2013;17(11):833–839. doi:10.1089/gtmb.2013.0291
   PubMed Web of Science ®Google Scholar
• Pan Y, Zhang J, Li J, Zhao W. Identification and Validation of Immune Markers in Coronary Heart Disease. Comput Math Methods Med. 2022;2022:2877679. doi:10.1155/2022/2877679
   PubMed Web of Science ®Google Scholar
• Goncharova IA, Bragina E, Zhalsanova I, Freidin MB, Nazarenko MS. Putative regulatory functions of SNPs associated with bronchial asthma, arterial hypertension and their comorbid phenotype. Vavilovskii Zhurnal Genet Selektsii. 2021;25(8):855–863. doi:10.18699/VJ21.099
   PubMed Web of Science ®Google Scholar
• Yang J, Patil RV, Yu H, Gordon M, Wax MB. T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma. Am J Ophthalmol. 2001;131(4):421–426. doi:10.1016/S0002-9394(00)00862-X
   PubMed Web of Science ®Google Scholar
• Huang P, Qi Y, Xu YS, et al. Serum cytokine alteration is associated with optic neuropathy in human primary open angle glaucoma. J Glaucoma. 2010;19(5):324–330. doi:10.1097/IJG.0b013e3181b4cac7
   PubMed Web of Science ®Google Scholar
• Fernandez IZ, Baxter RM, Garcia-Perez JE, et al. A novel human IL2RB mutation results in T and NK cell–driven immune dysregulation. J Exp Med. 2019;216(6):1255–1267. doi:10.1084/jem.20182015
   PubMed Web of Science ®Google Scholar
• Ji YW, Mittal SK, Hwang HS, et al. Lacrimal gland–derived IL-22 regulates IL-17-mediated ocular mucosal inflammation. Mucosal Immunol. 2017;10(5):1202–1210. doi:10.1038/mi.2016.119
   PubMed Web of Science ®Google Scholar
• Keller KE. Analysis of interleukin-20 receptor complexes in trabecular meshwork cells and effects of cytokine signaling in anterior segment perfusion culture. Mol Vis. 2019;25:266–282.
   PubMed Web of Science ®Google Scholar
• Mossner S, Kuchner M, Fazel Modares N, et al. Synthetic interleukin 22 (IL-22) signaling reveals biological activity of homodimeric IL-10 receptor 2 and functional cross-talk with the IL-6 receptor gp130. J Biol Chem. 2020;295(35):12378–12397. doi:10.1074/jbc.RA120.013927
   PubMed Web of Science ®Google Scholar
• Lécart S, Morel F, Noraz N, et al. IL‐22, in contrast to IL‐10, does not induce Ig production, due to absence of a functional IL‐22 receptor on activated human B cells. Int Immunol. 2002;14(11):1351–1356. doi:10.1093/intimm/dxf096
   PubMed Web of Science ®Google Scholar
• Mallela LS, Sharma P, Rao TSR, Roy S. Recombinant IL-22 promotes protection in a murine model of Aspergillus flavus keratitis and mediates host immune responses in human corneal epithelial cells. Cellular Microbiology. 2021;23(9):e13367. doi:10.1111/cmi.13367
   PubMed Web of Science ®Google Scholar
• Kong X, Feng D, Mathews S, Gao B. Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease. J Gastroenterol Hepatol. 2013;28(S1):56–60. doi:10.1111/jgh.12032
   PubMedGoogle Scholar
• Mitra A, Raychaudhuri SK, Raychaudhuri SP. Functional role of IL-22 in psoriatic arthritis. Arthritis Res Therapy. 2012;14(2):R65. doi:10.1186/ar3781
   PubMed Web of Science ®Google Scholar
• Lifshiz Zimon R, Lerman G, Elharrar E, et al. Ultrasound targeting of Q-starch/miR-197 complexes for topical treatment of psoriasis. J Control Release. 2018;284:103–111. doi:10.1016/j.jconrel.2018.05.040
   PubMed Web of Science ®Google Scholar
• Desmet E, Van Gele M, Grine L, Remaut K, Lambert J. Towards the development of a RNAi-based topical treatment for psoriasis: proof-of-concept in a 3D psoriasis skin model. Exp Dermatol. 2018;27(5):463–469. doi:10.1111/exd.13414
   PubMed Web of Science ®Google Scholar
• Zhang S, Yang G. IL22RA1/JAK/STAT Signaling Acts As a Cancer Target Through Pan-Cancer Analysis. Front Immunol. 2022;13:915246. doi:10.3389/fimmu.2022.915246
   PubMed Web of Science ®Google Scholar
• Dinarte VRP, Silva WA, Baccarin ARD, Tamashiro E, Valera FC, Anselmo-Lima WT. Association of interleukin 22 receptor subunit alpha 1 gene polymorphisms with chronic rhinosinusitis. Br J Otorhinolaryngol. 2021;87(5):505–511. doi:10.1016/j.bjorl.2019.10.006
   PubMed Web of Science ®Google Scholar
• Endam LM, Bossé Y, Filali-Mouhim A, et al. Polymorphisms in the interleukin-22 receptor alpha-1 gene are associated with severe chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2009;140(5):741–747. doi:10.1016/j.otohns.2008.12.058
   PubMed Web of Science ®Google Scholar
• Mattapallil MJ, Kielczewski JL, Zárate-Bladés CR, et al. Interleukin 22 ameliorates neuropathology and protects from central nervous system autoimmunity. J Autoimmun. 2019;102:65–76. doi:10.1016/j.jaut.2019.04.017
   PubMed Web of Science ®Google Scholar
• Lindborg JA, Tran NM, Chenette DM, et al. Optic nerve regeneration screen identifies multiple genes restricting adult neural repair. Cell Rep. 2021;34(9):108777. doi:10.1016/j.celrep.2021.108777
   PubMed Web of Science ®Google Scholar
• Li J, Liu W, Wang Y, et al. Salidroside Inhibits Ganglion Cell Apoptosis by Suppressing the Müller Cell Inflammatory Response in Diabetic Retinopathy. Curr Eye Res. 2023;1(2):1–12. doi:10.1080/02713683.2023.2204208
   Google Scholar
• Wang Y, Yu H, Li J, et al. Th22 cells induce Müller cell activation via the Act1/TRAF6 pathway in diabetic retinopathy. Cell Tissue Res. 2022;390(3):367–383. doi:10.1007/s00441-022-03689-8
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhang F, Pan Z, Luo H, Liu K, Duan X. LncRNA NR_003923 promotes cell proliferation, migration, fibrosis, and autophagy via the miR-760/miR-215-3p/IL22RA1 axis in human Tenon’s capsule fibroblasts. Cell Death Dis. 2019;10(8):1–13. doi:10.1038/s41419-019-1829-1
   Web of Science ®Google Scholar
• Yu S, Tam ALC, Campbell R, Renwick N. Emerging Evidence of Noncoding RNAs in Bleb Scarring after Glaucoma Filtration Surgery. Cells. 2022;11(8):1301. doi:10.3390/cells11081301
   PubMed Web of Science ®Google Scholar
• Sonar S, Lal G. Role of Tumor Necrosis Factor Superfamily in Neuroinflammation and Autoimmunity. Front Immunol. 2015; 6. doi:10.3389/fimmu.2015.00364
   PubMed Web of Science ®Google Scholar
• Xu WD, Zhao Y, Liu Y. Role of the TWEAK/Fn14 pathway in autoimmune diseases. Immunol Res. 2016;64(1):44–50. doi:10.1007/s12026-015-8761-y
   PubMed Web of Science ®Google Scholar
• Vendrell J. TWEAK: a New Player in Obesity and Diabetes. Front Immunol. 2013;4:88. doi:10.3389/fimmu.2013.00488
   PubMed Web of Science ®Google Scholar
• Cheadle L, Tzeng CP, Kalish BT, et al. Visual Experience-Dependent Expression of Fn14 Is Required for Retinogeniculate Refinement. Neuron. 2018;99(3):525–539.e10. doi:10.1016/j.neuron.2018.06.036
   PubMed Web of Science ®Google Scholar
• Cheadle L, Rivera SA, Phelps JS, et al. Sensory Experience Engages Microglia to Shape Neural Connectivity through a Non-Phagocytic Mechanism. Neuron. 2020;108(3):451–468.e9. doi:10.1016/j.neuron.2020.08.002
   PubMed Web of Science ®Google Scholar
• Ebihara N, Nakayama M, Tokura T, Iwatsu M, Ushio H, Murakami A. Proinflammatory Effect of TWEAK/Fn14 Interaction in Human Retinal Pigment Epithelial Cells. Curr Eye Res. 2009;34(10):836–844. doi:10.3109/02713680903122037
   PubMed Web of Science ®Google Scholar
• Ameri H, Liu H, Liu R, et al. TWEAK/Fn14 Pathway Is a Novel Mediator of Retinal Neovascularization. Invest Ophthalmol Vis Sci. 2014;55(2):801. doi:10.1167/iovs.13-12812
   PubMed Web of Science ®Google Scholar
• El-Asrar AM A, De Hertogh G, Nawaz MI, et al. The Tumor Necrosis Factor Superfamily Members TWEAK, TNFSF15 and Fibroblast Growth Factor-Inducible Protein 14 Are Upregulated in Proliferative Diabetic Retinopathy. Ophthalmic Res. 2015;53(3):122–130. doi:10.1159/000369300
   PubMed Web of Science ®Google Scholar
• Maarouf A, Stephan D, Ranjeva MP, et al. High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis. J Transl Med. 2019;17(1):51. doi:10.1186/s12967-019-1789-3
   PubMedGoogle Scholar
• Karadag H, Saygili G, Yuksel R, Baris Usta M, Topcuoglu C, Erzin G. SERUM TNF- RELATED WEAK INDUCER OF APOPTOSIS (TWEAK), TNF- RELATED APOPTOSIS-INDUCING LIGAND (TRAIL) LEVELS IN PATIENTS WITH BIPOLAR DEPRESSION, MAJOR DEPRESSION AND A HEALTHY CONTROL GROUP. Psychiatria Danubina. 2021;33(br 3):314–319. doi:10.24869/psyd.2021.314
   PubMed Web of Science ®Google Scholar
• Schmidt FM, Koch J, Nowak C, et al. Ligands and receptors of the TNF superfamily are decreased in major depression and during early antidepressant therapy. J Psychiatr Res. 2019;119:116–121. doi:10.1016/j.jpsychires.2019.09.010
   PubMed Web of Science ®Google Scholar
• Melin EO, Dereke J, Hillman M. Low levels of soluble TWEAK, indicating on-going inflammation, were associated with depression in type 1 diabetes: a cross-sectional study. BMC Psychiatry. 2020;20(1):574. doi:10.1186/s12888-020-02977-3
   PubMed Web of Science ®Google Scholar
• Gubin D, Neroev V, Malishevskaya T, et al. Depression scores are associated with retinal ganglion cells loss. J Affect Disord. 2023;333:290–296. doi:10.1016/j.jad.2023.04.039
   PubMed Web of Science ®Google Scholar
• Wang R, Chen B, Wei H, et al. Collecting and deactivating TGF-β1 hydrogel for anti-scarring therapy in post-glaucoma filtration surgery. Mater Today Bio. 2022;14:100260. doi:10.1016/j.mtbio.2022.100260
   PubMedGoogle Scholar
• Jelić-Ivanović Z, Bujišić N, Spasić S, Bogavac-Stanojević N, Spasojević-Kalimanovska V, Kotur-Stevuljević J. Circulating sTWEAK improves the prediction of coronary artery disease. Clin. Biochem. 2009;42(13):1381–1386. doi:10.1016/j.clinbiochem.2009.06.001
   PubMed Web of Science ®Google Scholar
• Urbonaviciene G, Martin-Ventura JL, Lindholt JS, et al. Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease. Atherosclerosis. 2011;219(2):892–899. doi:10.1016/j.atherosclerosis.2011.09.016
   PubMed Web of Science ®Google Scholar
• Fernández-Laso V, Sastre C, Valdivielso JM, et al. Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases. Atherosclerosis. 2015;239(2):358–363. doi:10.1016/j.atherosclerosis.2015.01.040
   PubMed Web of Science ®Google Scholar
• Turkmen K, Tonbul HZ, Erdur FM, et al. Soluble TWEAK independently predicts atherosclerosis in renal transplant patients. BMC Nephrol. 2013;14(1):144. doi:10.1186/1471-2369-14-144
   PubMedGoogle Scholar
• Perri P, Zauli G, Gonelli A, et al. TNF-Related Apoptosis Inducing Ligand in Ocular Cancers and Ocular Diabetic Complications. Biomed Res. Int. 2015;2015:e424019. doi:10.1155/2015/424019
   PubMed Web of Science ®Google Scholar
• Tisato V, Gonelli A, Voltan R, Secchiero P, Zauli G. Clinical perspectives of TRAIL: insights into central nervous system disorders. Cell Mol Life Sci. 2016;73(10):2017–2027. doi:10.1007/s00018-016-2164-7
   PubMed Web of Science ®Google Scholar
• Ikeda T, Hirata S, Fukushima S, et al. Dual Effects of TRAIL in Suppression of Autoimmunity: the Inhibition of Th1 Cells and the Promotion of Regulatory T Cells. J Immunol. 2010;185(9):5259–5267. doi:10.4049/jimmunol.0902797
   PubMed Web of Science ®Google Scholar
• Zhang XR, Zhang LY, Devadas S, Li L, Keegan AD, Shi YF. Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation. Cell Death Differ. 2003;10(2):203–210. doi:10.1038/sj.cdd.4401138
   PubMed Web of Science ®Google Scholar
• Guo C, Wu N, Niu X, Wu Y, Chen D, Guo W. Comparison of T Helper Cell Patterns in Primary Open-Angle Glaucoma and Normal-Pressure Glaucoma. Med Sci Monit. 2018;24:1988–1996. doi:10.12659/MSM.904923
   PubMed Web of Science ®Google Scholar
• Bell K, Holz A, Ludwig K, Pfeiffer N, Grus FH. Elevated Regulatory T Cell Levels in Glaucoma Patients in Comparison to Healthy Controls. Curr Eye Res. 2017;42(4):562–567. doi:10.1080/02713683.2016.1205629
   PubMed Web of Science ®Google Scholar
• Moreno M, Sáenz-Cuesta M, Castilló J, et al. Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis. J Neuroimmunol. 2013;263(1):152–154. doi:10.1016/j.jneuroim.2013.07.013
   PubMed Web of Science ®Google Scholar
• Mori K, Ikari Y, Jono S, et al. Association of serum TRAIL level with coronary artery disease. Thrombosis Research. 2010;125(4):322–325. doi:10.1016/j.thromres.2009.11.024
   PubMed Web of Science ®Google Scholar
• Cheng W, Liu F, Wang Z, et al. Soluble TRAIL Concentration in Serum Is Elevated in People with Hypercholesterolemia. PLoS One. 2015;10(12):e0144015. doi:10.1371/journal.pone.0144015
   PubMed Web of Science ®Google Scholar
• Angelopoulou E, Paudel YN, Shaikh MF, Piperi C. Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson’s disease: potential clinical and therapeutic implications. Pharmacol Res. 2020;158:104930. doi:10.1016/j.phrs.2020.104930
   PubMed Web of Science ®Google Scholar
• Breen KT, Anderson SR, Steele MR, Calkins DJ, Bosco A, Vetter ML. Loss of Fractalkine Signaling Exacerbates Axon Transport Dysfunction in a Chronic Model of Glaucoma. Front Neurosci. 2016;10. doi:10.3389/fnins.2016.00526
   PubMed Web of Science ®Google Scholar
• Jiang M, Xie H, Zhang C, et al. Enhancing fractalkine/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy. J Cell Mol Med. 2022;26(4):1229–1244. doi:10.1111/jcmm.17179
   PubMed Web of Science ®Google Scholar
• Chen G, Zhou Z, Sha W, et al. A novel CX3CR1 inhibitor AZD8797 facilitates early recovery of rat acute spinal cord injury by inhibiting inflammation and apoptosis. Int J Mol Med. 2020;45(5):1373–1384. doi:10.3892/ijmm.2020.4509
   PubMed Web of Science ®Google Scholar
• Begum G, Reddy R, Yakoub KM, Belli A, Davies DJ, Di Pietro V. Differential Expression of Circulating Inflammatory Proteins Following Sport-Related Traumatic Brain Injury. Int J Mol Sci. 2020;21(4):1216. doi:10.3390/ijms21041216
   PubMed Web of Science ®Google Scholar
• Liu C, Cui G, Zhu M, Kang X, Guo H. Neuroinflammation in Alzheimer’s disease: chemokines produced by astrocytes and chemokine receptors. Int J Clin Exp Pathol. 2014;7(12):8342–8355.
   PubMed Web of Science ®Google Scholar
• Wakefield D, Wildner G. Is glaucoma an autoimmune disease? Clin Transl Immunology. 2020;9(10):e1180. doi:10.1002/cti2.1180
   PubMed Web of Science ®Google Scholar
• Voisinne G, Gonzalez de Peredo A, Roncagalli R. CD5, an Undercover Regulator of TCR Signaling. Front Immunol. 2018;9:2900. doi:10.3389/fimmu.2018.02900
   PubMed Web of Science ®Google Scholar
• Calvo J, Places L, Espinosa G, et al. Identification of a natural soluble form of human CD5: circulating CD5. Tissue Antigens. 1999;54(2):128–137. doi:10.1034/j.1399-0039.1999.540203.x
   PubMedGoogle Scholar
• Ramos-Casals M, Font J, García-Carrasco M, et al. High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjögren’s syndrome. Rheumatology. 2001;40(9):1056–1059. doi:10.1093/rheumatology/40.9.1056
   PubMed Web of Science ®Google Scholar
• Aibar J, Martínez-Florensa M, Castro P, et al. Pattern of soluble CD5 and CD6 lymphocyte receptors in critically ill patients with septic syndromes. J Crit Care. 2015;30(5):914–919. doi:10.1016/j.jcrc.2015.04.120
   PubMed Web of Science ®Google Scholar
• Jamin C, Magadur G, Lamour A, et al. Cell-free CD5 in patients with rheumatic diseases. Immunol Lett. 1992;31(1):79–83. doi:10.1016/0165-2478(92)90014-f
   PubMed Web of Science ®Google Scholar
• Noh GW, Lee KY. Circulating soluble CD5 in atopic dermatitis. Mol Cells. 1998;8(5):618–622.
   PubMed Web of Science ®Google Scholar
• Andrés M V-D, Casadó-Llombart S, Català C, Leyton-Pereira A, Lozano F, Aranda F. Soluble CD5 and CD6: lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents. Cells. 2020;9(12):2589. doi:10.3390/cells9122589
   PubMed Web of Science ®Google Scholar
• Stolfi C, Troncone E, Marafini I, Monteleone G. Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer. Biomolecules. 2021;11(1):17. doi:10.3390/biom11010017
   Web of Science ®Google Scholar
• Roodnat AW, Callaghan B, Doyle C, et al. Genome-Wide RNA Sequencing of Human Trabecular Meshwork Cells Treated with TGF-β1: relevance to Pseudoexfoliation Glaucoma. Biomolecules. 2022;12(11):1693. doi:10.3390/biom12111693
   PubMed Web of Science ®Google Scholar
• Estrada LD, Oliveira-Cruz L, Cabrera D. Transforming Growth Factor Beta Type I Role in Neurodegeneration: implications for Alzheimer´s Disease. Curr Protein Pept Sci. 2014;19(12):1180–1188.
   Google Scholar
• Jorgensen MM, de la Puente P. Leukemia Inhibitory Factor: an Important Cytokine in Pathologies and Cancer. Biomolecules. 2022;12(2):217. doi:10.3390/biom12020217
   PubMed Web of Science ®Google Scholar
• Hui W, Bell M, Carroll G. SOLUBLE GLYCOPROTEIN 130 (gp130) ATTENUATES OSM- AND LIF-INDUCED CARTILAGE PROTEOGLYCAN CATABOLISM. Cytokine. 2000;12(2):151–155. doi:10.1006/cyto.1999.0550
   PubMed Web of Science ®Google Scholar
• Chollangi S, Wang J, Martin A, Quinn J, Ash JD. Preconditioning-induced protection from oxidative injury is mediated by leukemia inhibitory factor receptor (LIFR) and its ligands in the retina. Neurobiol Dis. 2009;34(3):535–544. doi:10.1016/j.nbd.2009.03.012
   PubMed Web of Science ®Google Scholar
• Yang JY, Lu B, Feng Q, et al. Retinal Protection by Sustained Nanoparticle Delivery of Oncostatin M and Ciliary Neurotrophic Factor Into Rodent Models of Retinal Degeneration. Trans Vision Sci Technol. 2021;10(9):6. doi:10.1167/tvst.10.9.6
   PubMed Web of Science ®Google Scholar
• Hu Q, Huang C, Wang Y, Wu R. Expression of leukemia inhibitory factor in the rat retina following acute ocular hypertension. Molecular Medicine Reports. 2015;12(5):6577–6583. doi:10.3892/mmr.2015.4287
   PubMed Web of Science ®Google Scholar
• Benito-Gutiérrez E, Garcia-Fernàndez J, Comella JX. Origin and evolution of the Trk family of neurotrophic receptors. Mol Cell Neurosci. 2006;31(2):179–192. doi:10.1016/j.mcn.2005.09.007
   PubMed Web of Science ®Google Scholar
• Uhlén M, Fagerberg L, Hallström BM, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419. doi:10.1126/science.1260419
   PubMed Web of Science ®Google Scholar
• Claes M, De Groef L, Moons L. Target-Derived Neurotrophic Factor Deprivation Puts Retinal Ganglion Cells on Death Row: cold Hard Evidence and Caveats. Int J Mol Sci. 2019;20(17):4314. doi:10.3390/ijms20174314
   PubMed Web of Science ®Google Scholar
• Gupta A, Galletti JG, Yu Z, Burgess K, de Paiva CS AB. C’s of Trk Receptors and Their Ligands in Ocular Repair. Int J Mol Sci. 2022;23(22):14069. doi:10.3390/ijms232214069
   PubMed Web of Science ®Google Scholar
• Nikoletopoulou V, Lickert H, Frade JM, et al. Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature. 2010;467(7311):59–63. doi:10.1038/nature09336
   PubMed Web of Science ®Google Scholar
• Karlsson M, Zhang C, Méar L, et al. A single-cell type transcriptomics map of human tissues. Sci Adv. 2021;7(31):eabh2169. doi:10.1126/sciadv.abh2169
   PubMed Web of Science ®Google Scholar
• Lukowski SW, Lo CY, Sharov AA, et al. A single-cell transcriptome atlas of the adult human retina. EMBO J. 2019;38(18):e100811. doi:10.15252/embj.2018100811
   PubMed Web of Science ®Google Scholar
• Cui Q, Tang LS, Hu B, So KF, Yip HK. Expression of trkA, trkB, and trkC in Injured and Regenerating Retinal Ganglion Cells of Adult Rats. Invest Ophthalmol Visual Sci. 2002;43(6):1954–1964.
   PubMed Web of Science ®Google Scholar
• Guo Y, Johnson E, Cepurna W, Jia L, Dyck J, Morrison JC. Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma? Exp Eye Res. 2009;89(6):921–933. doi:10.1016/j.exer.2009.08.003
   PubMed Web of Science ®Google Scholar
• Ogłodek EA, Just MJ, Szromek AR, Araszkiewicz A. Melatonin and neurotrophins NT-3, BDNF, NGF in patients with varying levels of depression severity. Pharmacol Rep. 2016;68(5):945–951. doi:10.1016/j.pharep.2016.04.003
   PubMed Web of Science ®Google Scholar
• Karan D. CCL23 in Balancing the Act of Endoplasmic Reticulum Stress and Antitumor Immunity in Hepatocellular Carcinoma. Front Oncol. 2021;11. doi:10.3389/fonc.2021.727583
   Web of Science ®Google Scholar
• Castillo L, Rohatgi A, Ayers CR, et al. Associations of Four Circulating Chemokines with Multiple Atherosclerosis Phenotypes in a Large Population-Based Sample: results from the Dallas Heart Study. J Interferon Cytokine Res. 2010;30(5):339–347. doi:10.1089/jir.2009.0045
   PubMed Web of Science ®Google Scholar
• Faura J, Bustamante A, Penalba A, et al. CCL23: a Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer’s Disease. J Alzheimers Dis. 2020;73(4):1585–1595. doi:10.3233/JAD-190753
   PubMed Web of Science ®Google Scholar
• Spaeth GL, Lopes JF, Junk AK, Grigorian AP, Henderer J. Systems for staging the amount of optic nerve damage in glaucoma: a critical review and new material. Surv Ophthalmol. 2006;51(4):293–315. doi:10.1016/j.survophthal.2006.04.008
   PubMed Web of Science ®Google Scholar
• Bayer A, Harasymowycz P, Henderer JD, Steinmann WG, Spaeth GL. Validity of a new disk grading scale for estimating glaucomatous damage: correlation with visual field damage. Am J Ophthalmol. 2002;133(6):758–763. doi:10.1016/s0002-9394(02)01422-8
   PubMed Web of Science ®Google Scholar
• Sulak R, Liu X, Smedowski A. The concept of gene therapy for glaucoma: the dream that has not come true yet. Neural Regeneration Res. 2024;19(1):92–99. doi:10.4103/1673-5374.375319
   PubMedGoogle Scholar